ArticleThe oncologist2021

A Phase I Open-Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26-104/RFASE in Patients with Advanced Solid Malignancies.

Ruben S A Goedegebuure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.